NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The National Institutes of Health (NIH), along with multiple NIH Institutes and Centers, the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA), plans to issue a Notice of Funding Opportunity (NOFO) for eligible United States small business concerns. This opportunity invites applications for Small Business Innovation Research (SBIR) grants across Phase I, Phase II, Direct to Phase II (NIH only), and Fast-Track (NIH only) categories using the R43/R44 activity codes. Although applications are not being accepted at this moment, the advance notice aims to allow potential applicants sufficient time to form meaningful collaborations and develop responsive research and development projects. This NOFO targets U.S. small businesses with research capabilities and technological expertise aligned with the R&D missions of the participating NIH components, CDC, and FDA. The funding will support innovation fostering collaborative investigations, encouraging partnerships among investigators with complementary expertise. Interested small businesses are advised to begin preparations for submission once the NOFO is officially published. For further information, interested parties can contact NIH SEED, the designated point of contact, via email or phone.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The National Institutes of Health (NIH), including the following NIH Institutes and Centers (ICs): NEI, NHLBI, NHGRI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDCR, NIDDK, NIDA, NIEHS, NIGMS, NIMH, NINDS, NINR, NIMHD, NLM, NCCIH, NCATS, ORIP, NCI and ORWH, along with the Centers for Disease Control (CDC), and the Food and Drug Administration (FDA), intends to publish a Notice of Funding Opportunity (NOFO) to invite eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) Phase I, Phase II, Direct to Phase II (NIH Only), and Fast-Track (NIH only) grant applications. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the R43/R44 activity code. United States small businesses that have the research capabilities and technological expertise to contribute to the R&D mission(s) of the NIH, CDC, and FDA awarding components identified in this NOFO are encouraged to begin to consider applying for this new NOFO. In addition, collaborative investigations combining expertise will be encouraged, and these investigators should also begin considering applying for this application.
